SCHEMBL2632511

SCHEMBL2632511

CC(C)(C)c1cc(C=O)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 3/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ ALDH1A1 P00352 7/20 0.55
▸ ALOX15 P16050 2/20 0.55
▸ NR1I2 O75469 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ MIF P14174 1/20 0.55
▸ TYR P14679 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ NFE2L2 Q16236 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ ALDH5A1 P51649 3/20 0.52
▸ ABAT P80404 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ TRIM24 O15164 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TRIM33 Q9UPN9 1/20 0.52
▸ RARB P10826 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30500661 1.00 PTGS2 (0.57) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL27872348 0.85 PTGS2 (0.53) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL3431682 0.84 PTGS2 (0.57) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL1827187 0.83 ALDH1A1 (0.59) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL1827186 0.83 ALDH1A1 (0.59) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL13257342 0.83 KDM4E (0.61) PTGS2KDM4ERAB9AALDH1A1ALDH5A1
Hydrochloric Acid SCHEMBL18281037 0.83 PTGS2 (0.52) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL29198614 0.82 KDM4E (0.50) PTGS2KDM4ERAB9AALDH1A1ALOX15
SCHEMBL29153372 0.82 GABBR2 (0.67) PTGS2KDM4EALDH1A1ALOX15NR1I2
SCHEMBL17058722 0.82 PTGS2 (0.50) PTGS2KDM4ERAB9AALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924815-A High-strength color rubber pavement material and preparation method thereof 江苏宝利国际投资股份有限公司 2024-04-26 — — CN claimed
CN-116622180-B Fireproof high-strength plastic pipe and preparation method thereof 河北通涛管业集团股份有限公司 2024-01-16 — — CN claimed
CN-116622180-A Fireproof high-strength plastic pipe and preparation method thereof 扬州鑫宸建材有限公司 2023-08-22 — — CN claimed
CN-116426160-A Camouflage ink formula and preparation method thereof 镇江银海镍铬化工有限公司 2023-07-14 — — CN claimed
JP-4587669-B2 — — 2010-11-24 — — JP claimed
JP-2005509662-A — — 2005-04-14 — — JP claimed
EP-1443915-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES Cutanix Corporation (US) 2004-08-11 — — EP claimed
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments CUTANIX CORPORATION 2003-08-21 — — US claimed
WO-2003043621-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES CUTANIX CORPORATION (US) 2003-05-30 — — WO claimed
JP-61057572-A — — None — — JP disclosed
CN-119684358-A Phosphite phenol compound, preparation method and application thereof, composite lubricating oil, and preparation method and application thereof 烟台先进材料与绿色制造山东省实验室 2025-03-25 — — CN disclosed
CN-119178816-A Detection method for antioxidant degradation impurities in injection 广州艾格生物科技有限公司 2024-12-24 — — CN disclosed
CN-118005982-B Preparation method of fireproof high-strength plastic pipe 任丘市华信电信器材有限公司 2024-11-22 — — CN disclosed
CN-118005982-A Preparation method of fireproof high-strength plastic pipe 扬州鑫宸建材有限公司 2024-05-10 — — CN disclosed
EP-0434394-A2 Compounds for treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1991-06-26 — — EP disclosed
EP-0391644-A2 Aryl-substituted rhodanine derivatives ELI LILLY AND COMPANY (US) 1990-10-10 — — EP disclosed
JP-S6157572-A NOVEL ALPHA-BENZYLIDENE-GAMMA-BUTYROLACTONE DERIVATIVE KANEGAFUCHI CHEM IND CO LTD 1986-03-24 — — JP disclosed
US-4429163-A CATALYTIC OXIDATION OF A P-CRESOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-01-31 — — US disclosed
EP-0012939-A1 Process for the production of 4-hydroxybenzaldehyde derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-07-09 — — EP disclosed
US-4064266-A Compositions for killing internal parasites containing 3-tert-alkyl-4-hydroxy-5-halo-benzylidene-malonitriles ICI AUSTRALIA LIMITED (AU) 1977-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments TYR, HRH1, HRH2 PTGS2 484/4885KDM4E 2158/4885RAB9A 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback